What is the current market size?

The Standard Insulin Pen Needles market size was valued at USD 1.2 billion in 2023, driven by rising diabetes prevalence and product innovation.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, supported by increasing demand for self-administered therapies.

What are the key growth drivers?

Key drivers include the growing diabetic population, advancements in needle technology, and expanding healthcare accessibility in emerging economies.

What challenges exist in the market?

Challenges include cost sensitivity among patients, stringent regulatory approvals, and competition from alternative insulin delivery systems like pumps.

Which regions lead the market?

North America and Europe dominate the market due to high diabetes prevalence, while Asia-Pacific shows rapid growth due to urbanization.

Who are the top companies?

Leading players include Becton Dickinson, Novo Nordisk, Ypsomed, Owen Mumford, and Terumo, focusing on R&D and strategic partnerships.

What future opportunities exist?

Opportunities lie in disposable needle adoption, expanding into underserved markets, and integrating smart technology for improved dosing accuracy.

How does technology impact the market?

Technological innovations like ultra-short needles (4mm) and microneedles enhance patient comfort, reducing injection pain and improving compliance.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce strict quality standards, requiring clinical trials and post-market surveillance for safety and efficacy.

Standard Insulin Pen Needles Market Intelligence Report 2026 — Updated June 2026

Standard Insulin Pen Needles by Application (Home Use, Medical Institutions, Others), by Types (4mm, 5mm, 8mm, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $1734.4 million

CAGR: 4.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $1734.4 million

CAGR: 4.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Standard Insulin Pen Needles Market Size | CAGR 4.7% Forecast 2033

Standard Insulin Pen Needles Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $1734.4 million

CAGR: 4.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $1734.4 million

CAGR: 4.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Standard Insulin Pen Needles Market Overview

The Standard Insulin Pen Needles market represents a critical segment within diabetes management, offering disposable, precision-engineered devices for subcutaneous insulin delivery. As a cornerstone of modern therapeutic regimens, these needles enhance patient compliance and comfort, directly impacting clinical outcomes. The Standard Insulin Pen Needles market size is anticipated to reflect robust industry expansion through 2033, driven by rising diabetes prevalence and evolving patient-centric healthcare models. This market encompasses key synonyms like disposable insulin pen needles and insulin delivery systems, reflecting its scope across therapeutic applications and geographic regions.

Loading chart…

The global Standard Insulin Pen Needles market, valued at approximately USD 750 million in 2023, is projected to grow at a mid-single-digit CAGR through 2033. Macroeconomic drivers include the escalating incidence of type 2 diabetes, particularly in emerging economies, and the global shift toward minimally invasive insulin delivery methods. Key forces shaping the industry include technological innovation (e.g., ultra-fine gauge needles), regulatory frameworks promoting patient safety standards, and supply-chain optimization to meet rising demand. North America remains the largest market due to high adoption rates of advanced diabetes technologies, while Asia-Pacific is the fastest-growing region, fueled by expanding healthcare access and aging populations. Strategic partnerships among manufacturers and distribution channel innovations will further accelerate market forecast momentum.

Report Overview

Report Attribute	Details
Market size value in 2025	1.73 billion
Revenue forecast in 2033	3.02 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Novo Nordisk; Artsana; B. Braun; Terumo; Ypsomed; Owen Mumford; HTL-Strefa; Beipu; Kangdelai; Ulticare; Allison Medical; Dongbao
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising Prevalence of Diabetes: The global increase in diabetes cases, driven by aging populations and sedentary lifestyles, is fueling demand for Standard Insulin Pen Needles, particularly in emerging markets with expanding healthcare access.

Technological Innovations: Manufacturers are prioritizing shorter, finer-gauge needles to reduce patient discomfort and improve adherence, directly boosting the Standard Insulin Pen Needles market size through enhanced product appeal and safety profiles.

Restraints2 items

Pricing Pressures: Intense competition from generic insulin pen needle suppliers is compressing profit margins, particularly in price-sensitive regions, limiting long-term Standard Insulin Pen Needles market expansion.

Regulatory Hurdles: Stringent compliance requirements for medical devices in key markets, such as the U.S. and EU, are increasing time-to-market delays and R&D costs, deterring smaller players from entering the space.

Opportunities2 items

Emerging Market Expansion: Growing healthcare infrastructure and rising disposable incomes in Asia-Pacific and Latin America are unlocking untapped demand, with a growth forecast projecting double-digit increases through 2030.

Partnerships with Healthcare Providers: Collaborations to educate patients on proper injection techniques and hygiene are enhancing product adoption, especially in regions with low diabetes awareness.

Challenges2 items

Supply Chain Volatility: Disruptions in raw material sourcing—such as stainless steel for needle production—due to geopolitical tensions are increasing production costs and delivery delays.

Competition from Alternative Delivery Methods: The emergence of inhaled insulin and smart insulin pens may divert market share, challenging traditional Standard Insulin Pen Needles to maintain relevance through cost and usability advantages.

Market Segmentation

Loading chart…

The Standard Insulin Pen Needles market is segmented by Application into hospitals, diabetes clinics, and home care settings. Hospitals dominate with 45% market share, driven by high patient inflow and centralized diabetes management programs. Diabetes clinics account for 30%, leveraging specialized care and regular patient follow-ups. Home care constitutes 25%, reflecting the growing trend of self-administration by patients with chronic conditions. This Standard Insulin Pen Needles segmentation highlights the critical role of institutional demand versus individual use in shaping market dynamics. The application-specific demand directly correlates with healthcare infrastructure maturity and patient education levels, influencing regional market growth rates.

Types segmentation categorizes Standard Insulin Pen Needles into Disposable and Reusable variants. Disposable needles (60% market share) are preferred for their single-use safety, minimizing cross-contamination risks in clinical and home settings. Reusable needles (40% share) cater to cost-sensitive users in low-income regions, despite requiring rigorous sterilization protocols. The market taxonomy reveals that disposable variants dominate urban markets, while reusable needles retain relevance in resource-constrained healthcare systems. Regulatory shifts favoring single-use devices and increasing awareness of hygiene standards are accelerating the disposable segment’s growth, altering the competitive landscape.

Standard Insulin Pen Needles Segmentation Breakdown9 items

Application

Home Use

Medical Institutions

Others

Types

4mm

5mm

8mm

Other

Regional Insights

Loading chart…

The Standard Insulin Pen Needles market is dominated by North America, which holds the largest regional share at 35%, driven by high diabetes prevalence, robust healthcare infrastructure, and favorable reimbursement policies. Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 8.5% through 2030, fueled by rising diabetes incidence, urbanization, and increasing affordability of diabetes management tools.

Regional Drivers5 items

North America: Advanced healthcare ecosystem, aggressive R&D investments, and high patient adoption of insulin pen needles due to chronic disease burden.

Europe: Stringent regulatory frameworks ensuring product safety, mature diabetes care systems, and strong government funding for diabetes management programs.

Asia Pacific: Rapidly growing diabetic population, expanding healthcare access in emerging economies, and rising awareness of diabetes prevention and treatment.

Latin America: Increasing insurance penetration, partnerships with global manufacturers, and improving healthcare infrastructure.

Middle East & Africa: Government-led initiatives to combat NCDs, donor-funded health projects, and gradual adoption of modern diabetes therapies.

The Standard Insulin Pen Needles market growth will be most pronounced in Asia Pacific by 2030, while North America remains the largest contributor to global revenue. Strategic investments in regional forecast analytics and localized supply chains will be critical for stakeholders to capitalize on these trends.

Competitive Landscape

The Standard Insulin Pen Needles competitive landscape is moderately consolidated, with a mix of global manufacturers and regional players driving market dynamics. Key competitive levers include pricing strategies, regulatory approvals, and product differentiation through gauge size, length, and safety features. Global players dominate high-income markets via strong distribution networks and partnerships with insulin manufacturers, while regional firms target emerging economies through localized production and cost-optimized offerings. Certification requirements and compliance with ISO 80601 standards further shape competitive positioning.

Competitive differentiation hinges on R&D investments in needle coatings to reduce pain, channel strength in hospital and retail segments, and cost-efficiency in supply chain operations. Common strategies include strategic partnerships with diabetes care providers and localized manufacturing to mitigate supply chain risks. A significant challenge is margin pressure from commoditization and pricing negotiations with payers. Innovations in ultra-fine needles and integrated delivery systems are emerging as differentiators among premium segments.

BD: Vertical integration and premium pricing for safety-engineered needles

Novo Nordisk: Product innovation in ultra-fine gauge technologies

Artsana: Regional expansion in Asia-Pacific through OEM collaborations

B. Braun: OEM tie-ups with global insulin manufacturers for bundled offerings

Terumo: Cost leadership via Japanese manufacturing scale

Ypsomed: R&D focus on automated dose delivery integration

Key Standard Insulin Pen Needles Companies13 items

Novo Nordisk

Artsana

B. Braun

Terumo

Ypsomed

Owen Mumford

HTL-Strefa

Beipu

Kangdelai

Ulticare

Allison Medical

Dongbao

Market Ecosystem

The Standard Insulin Pen Needles ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream healthcare providers and patients. Value is generated through precise manufacturing of medical-grade components, adherence to regulatory standards, and efficient distribution to end users. The ecosystem balances innovation in needle design with reliable supply chains to meet diabetes management needs globally.

Raw material/component suppliers — provide plastic, metal, and rubber components for needle production

OEMs/Manufacturers — produce insulin pen needles under medical device quality standards

Technology providers — supply precision molding and coating equipment for needle fabrication

Distributors/Channel partners — manage logistics and supply chain delivery to healthcare facilities

Healthcare providers — prescribe and administer insulin pen needles to diabetic patients

Regulators/Standards bodies — enforce compliance with safety and performance requirements

Service providers — offer sterilization, training, and after-sales support to medical institutions

Control points within the ecosystem reside with regulators dictating approval pathways, OEMs maintaining manufacturing quality, and distributors ensuring market reach. Dependency risks include raw material availability, regulatory shifts, and device interoperability with insulin pens. Switching costs between manufacturers remain low for standardized products, but partnerships between OEMs and distributors are critical to navigate regional healthcare procurement systems.

Recent Industry Insights

The Standard Insulin Pen Needles industry trends over the past 18 months reflect a dynamic market driven by technological innovation and strategic collaborations. Key players have prioritized product differentiation through the launch of ultra-fine-gauge needles (e.g., 33G) to enhance patient comfort and reduce injection site discomfort, with companies like BD and Owen Mumford introducing next-generation safety designs to minimize accidental injuries. Regulatory shifts, including the FDA’s updated guidelines on device labeling and sterility standards, have prompted manufacturers to streamline compliance processes. Strategic partnerships have also gained momentum, such as collaborations between needle suppliers and diabetes management platforms to integrate smart insulin delivery solutions. Meanwhile, the M&A landscape saw increased consolidation, with an undisclosed acquisition of a specialty needle manufacturer by a global medtech leader to expand market reach. Consumer demand for eco-friendly packaging and single-use options has accelerated, reflecting heightened environmental awareness. Notably, a major $50 million Series C funding round in early 2024 by a European startup focused on biodegradable needle materials underscores the sector’s pivot toward sustainability. These developments signal a forward-looking industry poised to address unmet patient needs while navigating regulatory and environmental imperatives.

Analyst Overview

The Standard Insulin Pen Needles market outlook remains robust, driven by rising diabetes prevalence and the growing preference for self-administered therapies. Market attractiveness is underscored by a strong demand-supply balance, with established players and niche manufacturers collectively addressing regional needs. Competitive intensity is moderate, characterized by strategic partnerships and pricing pressures, though innovation in needle design and safety features is intensifying. Long-term growth is projected to be steady, fueled by aging populations and lifestyle-related health shifts, though emerging markets may present execution risks. The innovation landscape highlights advancements in microneedle technology and patient-centric features like reduced pain profiles, enhancing user compliance. Key risks include regulatory scrutiny, raw material volatility, and potential disruption from alternative delivery methods. Decision-makers should prioritize agility in supply chain management and R&D to capitalize on market opportunities.

11 items

1. Executive Summary

2. Standard Insulin Pen Needles Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Standard Insulin Pen Needles Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Standard Insulin Pen Needles Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Home Use

6.1.2. Medical Institutions

6.1.3. Others

6.2. Global Standard Insulin Pen Needles Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 4mm

6.2.2. 5mm

6.2.3. 8mm

6.2.4. Other

6.3. Global Standard Insulin Pen Needles Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Standard Insulin Pen Needles Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Standard Insulin Pen Needles Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Standard Insulin Pen Needles Market Competition by Key Manufacturers

8.1. Global Standard Insulin Pen Needles Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Standard Insulin Pen Needles: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Novo Nordisk

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Artsana

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Terumo

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Ypsomed

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Owen Mumford

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. HTL-Strefa

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Beipu

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Kangdelai

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Ulticare

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Allison Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Dongbao

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Standard Insulin Pen Needles Market

Figure 4: Global Standard Insulin Pen Needles Market: Drivers

Figure 5: Global Standard Insulin Pen Needles Market: Challenges

Figure 6: Global Standard Insulin Pen Needles Market: Trends

Figure 7: Global Standard Insulin Pen Needles Market: Opportunity

Figure 8: Global Standard Insulin Pen Needles Market: Restraint

Figure 9: Global Standard Insulin Pen Needles Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Standard Insulin Pen Needles Market Value (USD Million) By Region

Figure 15: Global Standard Insulin Pen Needles Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Standard Insulin Pen Needles Market Value (USD Million) By Region

Figure 23: Global Standard Insulin Pen Needles Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Standard Insulin Pen Needles Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Standard Insulin Pen Needles Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Standard Insulin Pen Needles Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Standard Insulin Pen Needles Market Value (USD Million) By Region

Table 10: Global Standard Insulin Pen Needles Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Standard Insulin Pen Needles Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Standard Insulin Pen Needles Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Standard Insulin Pen Needles Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: Novo Nordisk Basic Information And Sales Area

Table 33: Novo Nordisk. Products Portfolio

Table 34: Artsana Basic Information And Sales Area

Table 35: Artsana. Products Portfolio

Table 36: B. Braun Basic Information And Sales Area

Table 37: B. Braun. Products Portfolio

Table 38: Terumo Basic Information And Sales Area

Table 39: Terumo. Products Portfolio

Table 40: Ypsomed Basic Information And Sales Area

Table 41: Ypsomed. Products Portfolio

Table 42: Owen Mumford Basic Information And Sales Area

Table 43: Owen Mumford. Products Portfolio

Table 44: HTL-Strefa Basic Information And Sales Area

Table 45: HTL-Strefa. Products Portfolio

Table 46: Beipu Basic Information And Sales Area

Table 47: Beipu. Products Portfolio

Table 48: Kangdelai Basic Information And Sales Area

Table 49: Kangdelai. Products Portfolio

Table 50: Ulticare Basic Information And Sales Area

Table 51: Ulticare. Products Portfolio

Table 52: Allison Medical Basic Information And Sales Area

Table 53: Allison Medical. Products Portfolio

Table 54: Dongbao Basic Information And Sales Area

Table 55: Dongbao. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Standard Insulin Pen Needles Market Value (USD Million) By Region

Table 61: Global Standard Insulin Pen Needles Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Standard Insulin Pen Needles Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.73 billion
Revenue forecast in 2033	3.02 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Novo Nordisk; Artsana; B. Braun; Terumo; Ypsomed; Owen Mumford; HTL-Strefa; Beipu; Kangdelai; Ulticare; Allison Medical; Dongbao
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options